Nexxen Launches Health Offering to Reach Key Audiences with Accuracy and Scale
Nexxen (NASDAQ: NEXN) has announced the launch of Nexxen Health, a comprehensive advertising platform designed for health advertisers. The platform enables data-driven campaigns across display, linear, and Connected TV (CTV) formats while maintaining privacy compliance.
A key feature is the integration with PurpleLab, providing access to the largest medical and pharmaceutical claims database in the US. This partnership allows for enhanced audience targeting and reporting capabilities, with access to approximately 500 privacy-safe, contextually relevant healthcare audiences.
The platform combines an integrated DSP and SSP, offering health and pharmaceutical brands direct access to premium, omnichannel inventory. Key features include Nexxen Discovery for audience optimization through contextual refinement, and Nexxen TV Audiences for coordinating campaign reach across linear and digital channels using ACR data. Real-time optimization capabilities are planned for 2025.
Nexxen (NASDAQ: NEXN) ha annunciato il lancio di Nexxen Health, una piattaforma pubblicitaria completa progettata per gli inserzionisti nel settore della salute. La piattaforma consente campagne basate sui dati attraverso formati display, lineari e Connected TV (CTV), garantendo al contempo la conformità alla privacy.
Una caratteristica chiave è l'integrazione con PurpleLab, che fornisce accesso al più grande database di richieste mediche e farmaceutiche negli Stati Uniti. Questa partnership consente un miglioramento nel targeting del pubblico e nelle capacità di reporting, con accesso a circa 500 audience sanitarie pertinenti e sicure per la privacy.
La piattaforma combina un DSP e un SSP integrati, offrendo ai marchi della salute e della farmaceutica accesso diretto a un inventario premium e omnicanale. Le caratteristiche principali includono Nexxen Discovery per l'ottimizzazione del pubblico attraverso un affinamento contestuale e Nexxen TV Audiences per coordinare la portata delle campagne attraverso canali lineari e digitali utilizzando dati ACR. Le capacità di ottimizzazione in tempo reale sono previste per il 2025.
Nexxen (NASDAQ: NEXN) ha anunciado el lanzamiento de Nexxen Health, una plataforma publicitaria integral diseñada para anunciantes de salud. La plataforma permite campañas basadas en datos a través de formatos de display, lineales y Connected TV (CTV), manteniendo el cumplimiento de la privacidad.
Una característica clave es la integración con PurpleLab, que proporciona acceso a la base de datos más grande de reclamaciones médicas y farmacéuticas en los EE. UU. Esta asociación permite una mejora en la segmentación de la audiencia y las capacidades de informes, con acceso a aproximadamente 500 audiencias de salud relevantes y seguras para la privacidad.
La plataforma combina un DSP y un SSP integrados, ofreciendo a las marcas de salud y farmacéuticas acceso directo a inventario premium y omnicanal. Las características clave incluyen Nexxen Discovery para la optimización de la audiencia a través de un refinamiento contextual, y Nexxen TV Audiences para coordinar el alcance de las campañas a través de canales lineales y digitales utilizando datos ACR. Se planean capacidades de optimización en tiempo real para 2025.
Nexxen (NASDAQ: NEXN)은 건강 광고주를 위해 설계된 종합 광고 플랫폼인 Nexxen Health의 출시를 발표했습니다. 이 플랫폼은 개인 정보 보호 준수를 유지하면서 디스플레이, 선형 및 연결 TV(CTV) 형식의 데이터 기반 캠페인을 가능하게 합니다.
주요 기능 중 하나는 PurpleLab와의 통합으로, 미국에서 가장 큰 의료 및 제약 청구 데이터베이스에 대한 접근을 제공합니다. 이 파트너십은 약 500개의 개인 정보 보호가 안전하고 맥락적으로 관련된 건강 청중에 대한 접근을 통해 향상된 청중 타겟팅 및 보고 기능을 허용합니다.
이 플랫폼은 통합된 DSP와 SSP를 결합하여 건강 및 제약 브랜드가 프리미엄 옴니채널 인벤토리에 직접 접근할 수 있도록 합니다. 주요 기능으로는 맥락적 정제를 통해 청중 최적화를 위한 Nexxen Discovery와 ACR 데이터를 사용하여 선형 및 디지털 채널 전반에 걸쳐 캠페인 도달 범위를 조정하는 Nexxen TV Audiences가 있습니다. 실시간 최적화 기능은 2025년을 목표로 하고 있습니다.
Nexxen (NASDAQ: NEXN) a annoncé le lancement de Nexxen Health, une plateforme publicitaire complète conçue pour les annonceurs du secteur de la santé. La plateforme permet des campagnes basées sur les données à travers des formats display, linéaires et Connected TV (CTV), tout en respectant la conformité à la vie privée.
Une caractéristique clé est l'intégration avec PurpleLab, qui donne accès à la plus grande base de données de demandes médicales et pharmaceutiques aux États-Unis. Ce partenariat permet une meilleure ciblage de l'audience et des capacités de reporting, avec accès à environ 500 audiences de santé pertinentes et sécurisées pour la vie privée.
La plateforme combine un DSP et un SSP intégrés, offrant aux marques de santé et de pharmacie un accès direct à un inventaire premium et omnicanal. Les caractéristiques clés incluent Nexxen Discovery pour l'optimisation de l'audience grâce à un affinage contextuel, et Nexxen TV Audiences pour coordonner la portée des campagnes à travers des canaux linéaires et numériques en utilisant des données ACR. Des capacités d'optimisation en temps réel sont prévues pour 2025.
Nexxen (NASDAQ: NEXN) hat die Einführung von Nexxen Health angekündigt, einer umfassenden Werbeplattform, die für Gesundheitswerber konzipiert ist. Die Plattform ermöglicht datengestützte Kampagnen über Display-, lineare und Connected TV (CTV)-Formate und gewährleistet dabei die Einhaltung des Datenschutzes.
Ein zentrales Merkmal ist die Integration mit PurpleLab, die Zugang zur größten Datenbank für medizinische und pharmazeutische Ansprüche in den USA bietet. Diese Partnerschaft ermöglicht eine verbesserte Zielgruppenansprache und Reporting-Funktionen, mit Zugang zu etwa 500 datenschutzkonformen, kontextuell relevanten Gesundheitszielgruppen.
Die Plattform kombiniert einen integrierten DSP und SSP, der Gesundheits- und Pharmamarken direkten Zugang zu hochwertigem, omnichannel Inventar bietet. Zu den wichtigsten Funktionen gehören Nexxen Discovery zur Optimierung der Zielgruppe durch kontextuelle Verfeinerung und Nexxen TV Audiences zur Koordination der Kampagnenreichweite über lineare und digitale Kanäle mithilfe von ACR-Daten. Echtzeit-Optimierungsfunktionen sind für 2025 geplant.
- Strategic partnership with PurpleLab provides access to largest US medical claims database
- Platform offers integrated DSP and SSP solution reducing data loss and improving match rates
- Access to 500 privacy-safe healthcare audiences for programmatic advertising
- Real-time optimization features not available until 2025
Insights
Nexxen's launch of a specialized health offering represents a strategic expansion into the high-value pharmaceutical advertising vertical. By integrating PurpleLab's healthcare claims database with its existing technology stack, Nexxen has effectively created a differentiated solution addressing the unique challenges of healthcare marketing.
The healthcare advertising sector demands both precision targeting and stringent compliance with privacy regulations—requirements Nexxen appears positioned to address through this specialized platform. The integration leverages Nexxen's existing infrastructure (Discovery tool, DSP/SSP integration, and ACR data) while adding healthcare-specific capabilities, suggesting efficient resource allocation rather than building entirely new technology.
Access to "approximately 500 privacy-safe and contextually relevant" healthcare audiences represents meaningful scale in this specialized vertical. The endorsement from Klick Health, a respected healthcare marketing agency, provides valuable third-party validation that could accelerate adoption.
While this expansion won't transform Nexxen's business model overnight, it establishes a foothold in a premium advertising segment with typically higher margins and less price sensitivity than general digital advertising. Healthcare marketers generally prioritize targeting accuracy and compliance over cost, potentially supporting more favorable economics for Nexxen in this vertical.
Data-driven, end-to-end platform enables marketing strategies that ensure compliance while maximizing impact across display, linear & Connected TV
Innovative integration with leading healthcare analytics company PurpleLab provides powerful audience-building and reporting tools
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Nexxen (NASDAQ: NEXN), a global, flexible advertising platform with deep expertise in data and advanced TV, today announced the launch of Nexxen Health, a new offering enabling health advertisers to run data-driven advertising campaigns that efficiently reach audiences and maximize impact across traditional and emerging formats, including display, linear and Connected TV (“CTV”), while maintaining privacy compliance.
A strategic component of the offering – an innovative integration between Nexxen’s proprietary audience discovery tool and PurpleLab®, a healthcare analytics company that holds the largest medical and pharmaceutical claims database in the US – can add additional layers of accuracy to pharmaceutical advertising campaigns while also extending reach with new patient and healthcare provider audiences.
“In a fast-changing, fragmented advertising and regulatory landscape, it’s critical for health and pharmaceutical brands to leverage flexible technology and powerful data that keeps them agile, precise and ready to capitalize on the opportunities emerging across display, CTV and linear,” said Chance Johnson, Chief Commercial Officer, Nexxen. “Nexxen simplifies healthcare advertising by offering scalable, high-quality video inventory alongside unique medical and pharmaceutical data solutions. Our approach enables precise audience discovery while maintaining compliance, supported by advanced planning tools, for measurable results.”
“We applaud Nexxen’s ongoing commitment to developing innovative, new ways to enhance campaign reach, optimization and measurement in the healthcare space,” said Kristy Quagliariello, Vice President, Programmatic Media, Klick Health. “We have been using Nexxen Discovery to yield critical insights for our growing roster of life sciences clients and are energized by how its integration of PurpleLab’s data promises to add a layer of qualification to our audiences prior to activation, and generate added levels of accuracy and insights for our clients.”
Nexxen’s integrated DSP and SSP offer health and pharmaceutical brands a direct path to premium, omnichannel inventory, driving efficiencies by maximizing match rates, reducing data loss and enabling real-time measurement, with real-time optimization to come in 2025. The platform’s audience discovery tool, Nexxen Discovery, optimizes audience quality through contextual refinement, while Nexxen TV Audiences, a dataset incorporating Nexxen’s unique automatic content recognition (“ACR”) data, enables coordination of health and pharmaceutical campaign reach across linear and digital.
Augmenting the power of Nexxen Discovery is a partnership with PurpleLab that integrates healthcare data from the country’s largest healthcare claims database with Nexxen’s contextual targeting capabilities. Through this partnership, Nexxen Discovery users will have the ability to activate and measure outcomes on approximately 500 privacy-safe and contextually relevant, direct-to-consumer healthcare audiences programmatically.
ABOUT NEXXEN
Nexxen empowers advertisers, agencies, publishers and broadcasters around the world to utilize data and advanced TV in the ways that are most meaningful to them. Our flexible and unified technology stack comprises a demand-side platform (“DSP”) and supply-side platform (“SSP”), with the Nexxen Data Platform at its core. With streaming in our DNA, Nexxen’s robust capabilities span discovery, planning, activation, monetization, measurement and optimization – available individually or in combination – all designed to enable our partners to achieve their goals, no matter how far-reaching or hyper niche they may be.
Nexxen is headquartered in Israel and maintains offices throughout the United States, Canada, Europe and Asia-Pacific, and is traded on the Nasdaq (NEXN). For more information, visit www.nexxen.com
For more information, please contact:
Caroline Smith
Vice President, Communications, Nexxen
csmith@nexxen.com
Forward Looking Statement
This press release contains forward-looking statements, including forward-looking statements within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities and Exchange Act of 1934, as amended. Forward-looking statements are identified by words such as “anticipates,” “believes,” “expects,” “intends,” “may,” “can,” “will,” “estimates,” and other similar expressions. However, these words are not the only way Nexxen identifies forward-looking statements. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the launch of Nexxen’s health offering and any benefits or insights associated with the solutions as well as any benefits associated with any of Nexxen’s products and platforms including the Nexxen Marketplaces, Discovery Tool, cross-screen measurement tools, Data Platform and CTV offering. These statements are neither promises nor guarantees but involve known and unknown risks, uncertainties and other important factors that may cause Nexxen’s actual results, performance or achievements to be materially different from its expectations expressed or implied by the forward-looking statements, including, but not limited to, the following: negative global economic conditions; global conflicts and war, including the current terrorist attacks by Hamas, and the war and hostilities between Israel and Hamas and Israel and Hezbollah, and how those conditions may adversely impact Nexxen’s business, customers, and the markets in which Nexxen competes. Nexxen cautions you not to place undue reliance on these forward-looking statements. For a more detailed discussion of these factors, and other factors that could cause actual results to vary materially, interested parties should review the risk factors listed in the Company’s most recent Annual Report on Form 20-F, filed with the U.S. Securities and Exchange Commission (www.sec.gov) on March 5, 2025. Any forward-looking statements made by Nexxen in this press release speak only as of the date of this press release, and Nexxen does not intend to update these forward-looking statements after the date of this press release, except as required by law.
FAQ
What is the main feature of Nexxen Health's new advertising platform for NEXN investors?
How many healthcare audiences can advertisers target through NEXN's PurpleLab partnership?
When will NEXN implement real-time optimization features in their health advertising platform?
What targeting capabilities does Nexxen Health's platform (NEXN) offer for pharmaceutical advertising?
